Gene · 34
Papers1,869
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,869
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Resolution Structural Proteomics of Mitochondria Using the 'Build and Retrieve' Methodology. | Mol Cell Proteomics | 2023 | 37839702 | PubTator, text mining | PubMed |
| The Physiological and Pathological Role of Acyl-CoA Oxidation. | Int J Mol Sci | 2023 | 37834305 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages. | Int J Biol Sci | 2023 | 37781517 | PubTator, text mining | PubMed |
| Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4. | Cancer Biol Ther | 2023 | 37773732 | PubTator, text mining | PubMed |
| Host and HBV Interactions and Their Potential Impact on Clinical Outcomes. | Pathogens | 2023 | 37764954 | PubTator, text mining | PubMed |
| Decreased Fatty Acid Oxidation Gene Expression in Pre-Eclampsia According to the Onset and Presence of Intrauterine Growth Restriction. | Nutrients | 2023 | 37764661 | PubTator, text mining | PubMed |
| Case report: Diagnosis of a patient with Sifrim-Hitz-Weiss syndrome, development and epileptic encephalopathy-14, and medium chain acyl-CoA dehydrogenase deficiency. | Front Pediatr | 2023 | 37732012 | PubTator, text mining | PubMed |
| Portuguese Neonatal Screening Programme: A Retrospective Cohort Study of 18 Years of MS/MS. | Endocr Metab Immune Disord Drug Targets | 2023 | 37711117 | PubTator, text mining | PubMed |
| Fatty acid metabolism-related genes as a novel module biomarker for kidney renal clear cell carcinoma: Bioinformatics modeling with experimental verification. | Transl Oncol | 2023 | 37708719 | PubTator, text mining | PubMed |
| HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth. | Sci Rep | 2023 | 37670031 | PubTator, text mining | PubMed |
| Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients. | BMC Biol | 2023 | 37667308 | PubTator, text mining | PubMed |
| Harnessing metabolism of hepatic macrophages to aid liver regeneration. | Cell Death Dis | 2023 | 37644019 | PubTator, text mining | PubMed |
| Paeonol represses A549 cell glycolytic reprogramming and proliferation by decreasing m6A modification of Acyl-CoA dehydrogenase. | Chin J Physiol | 2023 | 37635484 | PubTator, text mining | PubMed |
| Lnc-Malat1 promotes slow myofiber-type transformation through sponging miR-129-5p in C2C12 myotubes. | Exp Cell Res | 2023 | 37634561 | PubTator, text mining | PubMed |
| Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy. | Metabolites | 2023 | 37623876 | PubTator, text mining | PubMed |
| Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer. | BMC Cancer | 2023 | 37612627 | PubTator, text mining | PubMed |
| Mitochondrial heterogeneity in diseases. | Signal Transduct Target Ther | 2023 | 37607925 | PubTator, text mining | PubMed |
| Fasting-Mimicking Diet Drives Antitumor Immunity against Colorectal Cancer by Reducing IgA-Producing Cells. | Cancer Res | 2023 | 37602826 | PubTator, text mining | PubMed |
| Genetics of enzymatic dysfunctions in metabolic disorders and cancer. | Front Oncol | 2023 | 37601653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/34/papers?page=8